Virtus LifeSci Biotech Products ETF
Save
About
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U. S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.
Biggest holdings
Financial Services
2.06%
Industrials
1.83%
Real Estate
1.67%
Utilities
1.16%
Real Estate
1.06%
Utilities
0.89%
Financial Services
0.85%
Similar securities
Based on sector and market capitalization
Report issue